Results 121 to 130 of about 222,802 (316)

Recent advances in anticoagulant therapy

open access: yes
This thesis reviews the traditional coagulation cascade and acknowledges the advances in biopharmacy that have led to an updated understanding of the coagulation pathway.
Nguyen Truong Dang, Khoa
core  

Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era

open access: yes, 2016
Peter P Toth1–3 1CGH Medical Center, Sterling, IL, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3University of Illinois School of Medicine, Peoria, IL, USA Background: Patients who have had a venous thromboembolic event are ...
Toth PP
core  

Reappraisal of Real‐World Management of Acute Cholecystitis in Elderly Patients Based on the Adherence to Tokyo Guidelines 2018 (TG18): A Multicenter Study on Anzu HPB Surgical Meeting

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This multicenter retrospective study analyzes real‐world management of acute cholecystitis in patients aged ≥ 70 years across five institutions, focusing on adherence and intentional deviation from TG18 recommendations. By classifying treatment strategies as TG18‐accordant, more aggressive, or more conservative, we reappraise current practice patterns.
Yuta Kobayashi   +7 more
wiley   +1 more source

New anticoagulant strategies in ST elevation myocardial infarction: Trials and clinical implications

open access: yes, 2008
Conor J McCann, Ian BA MenownCraigavon Cardiac Centre, Craigavon Area Hospital, Craigavon, Northern Ireland, UKAbstract: New data have re-established the importance of anticoagulation of patients with ST segment elevation myocardial infarction (STEMI ...
Conor J McCann, Ian BA Menown
core  

“Intrapericardial Approach” for Venous Outflow Reconstruction in Living‐Donor Liver Transplantation for Budd‐Chiari Syndrome: Surgical Techniques and LongTerm Outcomes

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Unlike deceased‐donor liver transplantation, living‐donor liver transplantation (LDLT) for Budd‐Chiari Syndrome (BCS) presents distinctive challenges in hepatic venous (HV)‐outflow reconstruction because diseased HV–inferior vena cava (IVC) cannot be entirely replaced with healthy donor vessels.
Koichiro Hata   +4 more
wiley   +1 more source

Emergency Cholecystectomy in Patients Classified as High Risk According to the Tokyo Guidelines 2018: A Real‐World Analysis

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Emergency cholecystectomy was evaluated in patients with acute cholecystitis classified as non‐recommended for surgery by the Tokyo Guidelines 2018. Major postoperative complications, rather than mortality, better reflected operative risk. Physiological instability, particularly ASA‐PS ≥ 3 and shock status, identified high‐risk patients, suggesting ...
Satoshi Mii   +9 more
wiley   +1 more source

Editorial: Venous thromboembolism and pregnancy

open access: yesFrontiers in Cardiovascular Medicine, 2022
Bernard Tardy, Laurent Bertoletti
doaj   +1 more source

Low-molecular-weight sulfonated chitosan as template for anticoagulant nanoparticles

open access: yes, 2018
Katja Heise,1,2 Mathias Hobisch,3,4 Liviu Sacarescu,5 Uros Maver,6 Josefine Hobisch,3 Tobias Reichelt,7 Marija Sega,6 Steffen Fischer,1 Stefan Spirk3,4 Members of EPNOE and NAWI Graz 1Institute of Plant and Wood Chemistry, Technische Universität ...
Maver U   +8 more
core  

Impact of Recanalization on Liver Hypertrophy after Portal Vein Embolization and the Role of Re‐Embolization

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This retrospective study of 249 patients undergoing hepatectomy after right portal vein embolization (PVE) demonstrated that major recanalization–defined as recanalization more than one segment within the embolized liver–was associated with impaired regeneration of the future liver remnant (FLR).
Masao Uemura   +9 more
wiley   +1 more source

Indications and outcomes of rivaroxaban use in cats

open access: yesFrontiers in Veterinary Science
IntroductionThe use of rivaroxaban, an oral direct factor Xa inhibitor, has only been described in a small number of publications in cats. The study objective was to describe the use of rivaroxaban in a large population of hospitalised cats.MethodsCases ...
Ella Yarsley   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy